Details of the Drug Formulations

General Information of Drug (ID: DMGV8QU)

Drug Name
Etravirine Drug Info
Synonyms
Intelence; DAPY deriv; Diaminopyrimidine deriv; R 165335; R165335; TMC 125; TMC125; Intelence (TN); Intelence(TM); R-165335; R165335-TMC125; TMC-125; Etravirine (JAN/USAN/INN); TMC-125/R-165335; 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile; 4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE; 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile; 65B; ETR
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus-1 infection 1C62 Approved [1]
Cross-matching ID
PubChem CID
193962
ChEBI ID
CHEBI:63589
CAS Number
269055-15-4
TTD ID
D0BP9C
VARIDT ID
DR00597
INTEDE ID
DR0671
ACDINA ID
D00259

Full List of Drug Formulations Containing This Drug

Etravirine 100 mg tablet
Company Formulation ID FDA Description
State of Florida DOH Central Pharmacy F07801 Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Hypromellose; Silicon dioxide; Cellulose, microcrystalline
RemedyRepack F07802 Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
------------------------------------------------------------------------------------
Etravirine 200 mg tablet
Company Formulation ID FDA Description
A-S Medication Solutions; Janssen Products; Physicians Total Care F07803 Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses
------------------------------------------------------------------------------------

References

1 Emerging antiviral drugs. Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416.